Estimation on conditional restricted mean survival time with counting process

J Biopharm Stat. 2019;29(5):800-809. doi: 10.1080/10543406.2019.1657129. Epub 2019 Aug 27.

Abstract

In traditional survival analyses, hazard ratio (HR) is commonly used to evaluate treatment effects. However, HR may not be easy to interpret. Restricted mean survival time is a viable alternative to HR, particularly when the proportional hazards assumption is not satisfied. We developed a conditional restricted mean survival time (CRMST) estimator for a time interval of interest using counting process. The variance of CRMST was estimated using a perturbation re-sampling method for asymptotic normality. The utility of our CRMST seems promising based on comprehensive simulation studies and a real data case study.

Keywords: Restricted mean survival time; proportional hazard; survival analyses.

MeSH terms

  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / mortality*
  • Double-Blind Method
  • Follow-Up Studies
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use
  • Proportional Hazards Models
  • Randomized Controlled Trials as Topic / methods
  • Randomized Controlled Trials as Topic / statistics & numerical data*
  • Stochastic Processes
  • Survival Rate / trends

Substances

  • Platelet Aggregation Inhibitors